All In Biotech

Drug Trial Radar · NCT03730662

A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)

Last checked: Nov 20, 2026Latest source record: Feb 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,002 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,002

Actual

Start

Nov 20, 2018

Primary completion

Jan 22, 2021

Study completion Apr 22, 2021

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 5, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the trial is to assess the efficacy and safety of tirzepatide taken once a week to insulin glargine taken once daily in participants with type 2 diabetes and increased cardiovascular risk. The study will last about 108 weeks and may include up to 30 visits.

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • TirzepatideDrug

    Administered SC.

  • Insulin GlargineDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)Time frame: Baseline, Week 52

Locations

216 sites in 15 countries. Site status is shown where the registry gives one.

  • Advanced Research Center

    Anaheim, California

  • Valley Clinical Trials, Inc.

    Covina, California

  • Marin Endocrine Associates

    Greenbrae, California

  • National Research Institute

    Huntington Park, California

  • Scripps Whittier Diabetes Institute

    La Jolla, California

  • First Valley Medical Group

    Lancaster, California

  • National Research Institute

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Monterey Endocrine & Diabetes Institute, Inc.

    Monterey, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Desert Medical Group Inc

    Palm Springs, California

  • Havana Research Institute

    Pasadena, California

  • Western University of Health Sciences

    Pomona, California

  • LCGK Research

    San Carlos, California

  • Olive View Medical Center

    Sylmar, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Touro University

    Vallejo, California

  • Coastal Metabolic Research Centre

    Ventura, California

  • Diablo Clinical Research

    Walnut Creek, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • ALL Medical Research, LLC

    Cooper City, Florida

  • Advanced Pharma Research

    Cutler Bay, Florida

  • South Florida Wellness & Clinical Research Institute

    Margate, Florida

  • Suncoast Research Group, LLC

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • Clinical Neuroscience Solutions Inc

    Orlando, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Primary Care Specialists, LLC

    Atlanta, Georgia

  • Rocky Mountain Diabetes and Osteoporosis Center

    Idaho Falls, Idaho

  • Solaris Clinical Research

    Meridian, Idaho

  • Saltzer Medical Group. P.A.

    Nampa, Idaho

  • Northwestern Feinberg School of Medicine

    Chicago, Illinois

  • NorthShore University HealthSystem

    Skokie, Illinois

  • University of Iowa Hospital & Clinic

    Iowa City, Iowa

  • Iowa Diabetes Research

    West Des Moines, Iowa

  • Cotton O'Neil Diabetes and Endocrinology Center

    Topeka, Kansas

  • Robley Rex VAMC

    Louisville, Kentucky

  • NECCR PrimaCare Research, LLC

    Fall River, Massachusetts

  • AA Medical Research Center

    Flint, Michigan

  • Troy Internal Medicine, PC

    Troy, Michigan

Showing 40 of 216 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.